Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LCK | P06239 | 1/20 | 0.72 |
| ▸ | FYN | P06241 | 1/20 | 0.72 |
| ▸ | MYC | P01106 | 1/20 | 0.58 |
| ▸ | CA12 | O43570 | 2/20 | 0.56 |
| ▸ | CA1 | P00915 | 2/20 | 0.56 |
| ▸ | CA2 | P00918 | 2/20 | 0.56 |
| ▸ | CA4 | P22748 | 2/20 | 0.56 |
| ▸ | CA6 | P23280 | 2/20 | 0.56 |
| ▸ | CA7 | P43166 | 2/20 | 0.56 |
| ▸ | CA9 | Q16790 | 2/20 | 0.56 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | TPMT | P51580 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | HPGD | P15428 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30415497 | 1.00 | LCK (0.72) | LCKFYNMYCCA12CA1 | |
| SCHEMBL25021458 | 0.91 | HTT (0.64) | LCKFYNMYCCA12CA1 | |
| SCHEMBL347214 | 0.90 | LCK (0.73) | LCKFYNMYCCA12CA1 | |
| SCHEMBL29765241 | 0.90 | LCK (0.73) | LCKFYNMYCCA12CA1 | |
| SCHEMBL2830233 | 0.90 | LCK (0.72) | LCKFYNMYCCA12CA1 | |
| SCHEMBL28719929 | 0.89 | KDM4E (0.63) | LCKFYNMYCHTTCYP3A4 | |
| SCHEMBL14915978 | 0.89 | LCK (0.60) | LCKFYNMYCCA12CA1 | |
| Hydrochloric Acid SCHEMBL22129893 | 0.88 | LCK (0.70) | LCKFYNMYCCA12CA1 | |
| SCHEMBL13912968 | 0.88 | LCK (0.64) | LCKFYNMYCCA12CA1 | |
| Hydrochloric Acid SCHEMBL8902783 | 0.87 | LCK (0.69) | LCKFYNMYCCA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 219 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111171085-A | Rhamnose donor protected by orthocarbonate, and preparation method and application thereof | 山东大学 | 2020-05-19 | — | — | CN | claimed |
| US-20050014951-A1 | Photoprotective and lightfastness-enhancing siloxanes | XEROX CORPORATION | 2005-01-20 | — | — | US | claimed |
| US-6803395-B2 | POLYSILOXANE HAVING THEREON A HYDROPHILIC MOIETY AND A LIGHTFASTNESS MOIETY | XEROX CORPORATION | 2004-10-12 | — | — | US | claimed |
| US-20030137570-A1 | Photoprotective and lightfastness-enhancing siloxanes | XEROX CORPORATION | 2003-07-24 | — | — | US | claimed |
| US-20030133886-A1 | Photoprotective and lightfastness-enhancing siloxanes | XEROX CORPORATION | 2003-07-17 | — | — | US | claimed |
| US-20030119940-A1 | Ink composition with improved lightfastness | XEROX CORPORATION | 2003-06-26 | — | — | US | claimed |
| US-6569511-B1 | Polysiloxane having a hydrophilic moiety and a lightfastness moiety; ink jet coating | XEROX CORPORATION | 2003-05-27 | — | — | US | claimed |
| CN-116200733-B | Metal material for plastic working | 日本帕卡濑精株式会社 | 2024-10-25 | — | — | CN | disclosed |
| WO-2023116902-A1 | SOS1 INHIBITOR | 北京望实智慧科技有限公司 | 2023-06-29 | — | — | WO | disclosed |
| WO-2023287730-A1 | TRICYCLIC COMPOUNDS | RECURIUM IP HOLDINGS, LLC (US) | 2023-01-19 | — | — | WO | disclosed |
| EP-3230339-B1 | EPOXY RESIN COMPOSITION, PREPREG, FIBER-REINFORCED PLASTIC MATERIAL, AND MANUFACTURING METHOD FOR FIBER-REINFORCED PLASTIC MATERIAL | TORAY INDUSTRIES (JP) | 2022-03-23 | — | — | EP | disclosed |
| EP-2656882-B1 | Golf ball | SUMITOMO RUBBER IND (JP) | 2021-06-09 | — | — | EP | disclosed |
| EP-3292893-B1 | GOLF BALL | SUMITOMO RUBBER IND (JP) | 2021-06-09 | — | — | EP | disclosed |
| EP-0373573-B1 | Recording material for ink jet printing | CIBA GEIGY AG (CH) | 1994-06-22 | — | — | EP | disclosed |
| US-5219848-A | Bactericides | ICI PHARMA (FR) | 1993-06-15 | — | — | US | disclosed |
| US-5098477-A | Aromatic ether derivatives as light stabilizers for organic materials | CIBA-GEIGY CORPORATION (US) | 1992-03-24 | — | — | US | disclosed |
| US-5073448-A | Containing light stabilizers | CIBA-GEIGY CORPORATION (US) | 1991-12-17 | — | — | US | disclosed |
| EP-0412763-A2 | Cephalosporins, processes for their preparation, pharmaceutical compositions containing them and intermediates therefor | ZENECA LIMITED (GB) | 1991-02-13 | — | — | EP | disclosed |
| CN-1043517-A | Ink for ink jet printing | CIBA GEIGY AG (CH) | 1990-07-04 | — | — | CN | disclosed |
| EP-0373574-A1 | Inks, especially for ink jet printing | CIBA-GEIGY AG (CH) | 1990-06-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050014951-A1 | Photoprotective and lightfastness-enhancing siloxanes | LRRFIP1, LRRC59, MMS19 | LCK 4708/4885FYN 4073/4885MYC 4357/4885 |
| US-20030133886-A1 | Photoprotective and lightfastness-enhancing siloxanes | ITGA1, ITGB1, ITGB8 | LCK 4773/4885FYN 4171/4885MYC 4598/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.